Julia Lainster

The drumbeat behind next-generation biologics has been unmistakable, yet the loudest voices in today’s pipelines keep returning to a sobering reality: delivery is not polish at the finish line, it is the race itself, where fragile molecules, strict dosing windows, and hard-to-reach tissues force

For thousands living with spinal muscular atrophy who aged out of early approvals, the FDA’s greenlight of an intrathecal gene therapy redrew the treatment map and challenged long‑held limits. The authorization of Itvisma, an intrathecal formulation of onasemnogene abeparvovec for patients two

The scale of diabetic eye screening would swamp any manual system left to grow unchecked, with more than four million people eligible in England and tens of millions of images flowing through a pipeline that still leans on multiple human graders per case to keep patients safe and services moving.

Julia Lainster sits down with Ivan Kairatov, a seasoned biopharma leader with deep experience in oncology R&D, to unpack the latest data from OptiTROP-Lung05 and what it could mean for first-line NSCLC. They explore how a TROP2-directed antibody-drug conjugate combined with an immune checkpoint

Could a single seed pull double duty against inflammation, oxidative stress, microbes, and metabolic drift without the side-effect ledger that shadows many prescriptions, and could it do so in a way that complements rather than competes with standard care? That is the provocation driving a surge of

Wrist fractures, specifically distal radius fractures, rank among the most frequent orthopedic injuries, particularly impacting older adults who are prone to falls or trauma. These injuries often disrupt daily routines with persistent pain and limited mobility, making recovery a frustratingly slow

In an era where digital innovation drives most industries forward, the healthcare sector often finds itself tethered to outdated technologies like fax machines, largely due to stringent privacy regulations and interoperability barriers. At the University of Pennsylvania Health System (UPHS), part

In the intricate landscape of drug discovery, pinpointing effective inhibitors for Protein Tyrosine Phosphatase 1B (PTP1B) stands as a monumental challenge with profound implications for treating metabolic disorders such as diabetes and obesity. PTP1B is a key player in regulating insulin signaling

I'm thrilled to sit down with Ivan Kairatov, a renowned biopharma expert whose pioneering work in technology and innovation has pushed boundaries in medical research and development. With a deep focus on cutting-edge solutions, Ivan has been at the forefront of exploring focused ultrasound as a

In a significant stride toward better healthcare access, Upper River Valley Hospital in New Brunswick, Canada, has welcomed the arrival of a prefabricated modular MRI unit, marking a pivotal moment for the region’s medical landscape. This development promises to bring advanced diagnostic imaging